| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/26/2002 | US20020137664 Substituted piperidines as melanocortin-4 receptor agonists |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440106A1 Substituted benzopyranones as telomerase inhibitors |
| 09/26/2002 | CA2439539A1 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 09/26/2002 | CA2404701A1 Triazole compounds having amide linkage |
| 09/25/2002 | EP1243584A1 Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
| 09/25/2002 | EP1243583A1 Heterocyclic compounds having sulfonamide groups |
| 09/25/2002 | EP1243581A1 Pyridinium compounds useful for the treatment of AGE-related diseases |
| 09/25/2002 | EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use |
| 09/25/2002 | EP1243268A1 Medicinal composition |
| 09/25/2002 | EP1242426A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 09/25/2002 | EP1242418A1 Antidiabetic thiazolidinediones and their preparation |
| 09/25/2002 | EP1242417A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| 09/25/2002 | EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242411A1 Indole derivatives for the treatment of depression and anxiety |
| 09/25/2002 | EP1242409A2 Substituted bisindolylmaleimides |
| 09/25/2002 | EP1242403A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242396A1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors |
| 09/25/2002 | EP1242081A1 Caspases and apoptosis |
| 09/25/2002 | EP1242072A1 Antipsychotic heterocycle compounds |
| 09/25/2002 | EP1242069A2 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 09/25/2002 | EP1144408B1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application |
| 09/25/2002 | EP1021405B1 Azetidinone derivatives for the treatment of hcmv infections |
| 09/25/2002 | EP1001951B1 Thiazole derivatives, method for their production and use |
| 09/25/2002 | EP0923570B1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 09/25/2002 | CN1371365A Piperidine alcohols |
| 09/25/2002 | CN1371360A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1091443C New imidazoline compounds, process for preparing them and pharmaceutical composition containing them |
| 09/24/2002 | US6455698 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455579 Useful in photochemical polymerization, dye laser, and electroluminescence. |
| 09/24/2002 | US6455571 Inhibitors of neuraminidases |
| 09/24/2002 | US6455535 Insecticides |
| 09/24/2002 | US6455528 Tumor necrosis factor antagonist and/or interleukin promoter; antiallergens, antiinflammatory agents; autoimmune disease treatment |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
| 09/24/2002 | US6455522 Cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455472 Herbicides, acaricides, nematicides and insecticides for crops |
| 09/24/2002 | CA2261426C Benzimidazole cyclooxygenase-2-inhibitors |
| 09/24/2002 | CA2246584C Method of treating tourette's syndrome |
| 09/20/2002 | WO2001070692A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 09/20/2002 | CA2403807A1 Heterocyclic acylsulfimides,processes for their preparation,compositionscomprising them and their use as pesticides |
| 09/19/2002 | WO2002072858A2 Degradation of epothilones and ethynyl substituted epothilones |
| 09/19/2002 | WO2002072577A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 09/19/2002 | WO2002072572A1 Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 09/19/2002 | WO2002072570A2 Non-imidazole compounds as histamine h3 antagonists |
| 09/19/2002 | WO2002072564A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 09/19/2002 | WO2002072562A1 Medicinal composition containing 1,3-thiazine derivative |
| 09/19/2002 | WO2002072561A1 Piperazinyltriazines as estrogen receptor modulators |
| 09/19/2002 | WO2002072543A2 Rxr activating molecules |
| 09/19/2002 | WO2002072085A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 09/19/2002 | WO2002072009A2 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 09/19/2002 | WO2002053534A8 Vla-4 inhibitors |
| 09/19/2002 | WO2002050070A3 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 09/19/2002 | WO2002014311A3 Urea compounds and methods of uses |
| 09/19/2002 | US20020133023 Antitumor agents, osteoporosis |
| 09/19/2002 | US20020133021 Bactericides |
| 09/19/2002 | US20020133016 Hypoglycemic agents; antilipemic agents; antidiabetic agents |
| 09/19/2002 | US20020132853 Diaryl piperazines and related compounds useful in the treatment of a chronic and acute pain conditions, itch and urinary incontinence. |
| 09/19/2002 | US20020132836 Compounds and methods for modulating CCR4 function |
| 09/19/2002 | US20020132822 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/19/2002 | US20020132820 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/19/2002 | US20020132812 Oral hypoglycaemic agents |
| 09/19/2002 | US20020132809 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 09/19/2002 | DE10110438A1 Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2473156A1 Rxr activating molecules |
| 09/19/2002 | CA2440555A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 09/19/2002 | CA2440184A1 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 09/19/2002 | CA2437707A1 Degradation of epothilones and ethynyl substituted epothilones |
| 09/18/2002 | EP1241168A1 Human NK3 receptor-selective antagonist compounds, process for their obtention and pharmaceutical compositons containing them |
| 09/18/2002 | EP1240906A1 Preventives or remedies for arrhythmia |
| 09/18/2002 | EP1240166A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240165A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240164A1 Benzazole derivatives and their use as jnk modulators |
| 09/18/2002 | EP1240162A2 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 09/18/2002 | EP1240158A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 09/18/2002 | EP1240154A1 Serine protease inhibitors |
| 09/18/2002 | EP1240153A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240147A1 Potassium channel inhibitors |
| 09/18/2002 | EP1240145A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 09/18/2002 | EP1240144A2 Compound having effect of promoting neuron differentiation |
| 09/18/2002 | EP1239877A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN $g(a) V?$g(b) 3? RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 09/18/2002 | EP1239852A2 Bissulfonamide derivatives as enzyme inhibitors |
| 09/18/2002 | EP1100798B1 Benzazole, benzoxazole, benzthiazole and benzimidazole derivatives |
| 09/18/2002 | EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | EP0757681B1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| 09/18/2002 | CN1370162A Derivatives of trifluoromethylpyri(mi)dine |
| 09/18/2002 | CN1370161A Novel quaternary ammonium compounds, its prepn. methods and medicinal application |
| 09/18/2002 | CN1370154A Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/18/2002 | CN1370047A Fungicides |